DK3629720T3 - Ikke-humane dyr, der er i stand til at omarrangere DH-DH i immunoglobulin-tungkæde-kodningssekvenser - Google Patents
Ikke-humane dyr, der er i stand til at omarrangere DH-DH i immunoglobulin-tungkæde-kodningssekvenser Download PDFInfo
- Publication number
- DK3629720T3 DK3629720T3 DK19737613.0T DK19737613T DK3629720T3 DK 3629720 T3 DK3629720 T3 DK 3629720T3 DK 19737613 T DK19737613 T DK 19737613T DK 3629720 T3 DK3629720 T3 DK 3629720T3
- Authority
- DK
- Denmark
- Prior art keywords
- rearranging
- heavy chain
- coding sequences
- immunoglobulin heavy
- human animals
- Prior art date
Links
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 title 1
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 title 1
- 241001465754 Metazoa Species 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/20—Animal model comprising regulated expression system
- A01K2217/206—Animal model comprising tissue-specific expression system, e.g. tissue specific expression of transgene, of Cre recombinase
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
- C12N2015/8518—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic expressing industrially exogenous proteins, e.g. for pharmaceutical use, human insulin, blood factors, immunoglobulins, pseudoparticles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
- C12N2015/8527—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic for producing animal models, e.g. for tests or diseases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/02—Cells from transgenic animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Environmental Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862685203P | 2018-06-14 | 2018-06-14 | |
US201862702206P | 2018-07-23 | 2018-07-23 | |
US201962812580P | 2019-03-01 | 2019-03-01 | |
PCT/US2019/037285 WO2019241692A1 (en) | 2018-06-14 | 2019-06-14 | Non-human animals capable of dh-dh rearrangement in the immunoglobulin heavy chain coding sequences |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3629720T3 true DK3629720T3 (da) | 2022-03-07 |
Family
ID=67220854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK19737613.0T DK3629720T3 (da) | 2018-06-14 | 2019-06-14 | Ikke-humane dyr, der er i stand til at omarrangere DH-DH i immunoglobulin-tungkæde-kodningssekvenser |
Country Status (20)
Country | Link |
---|---|
US (2) | US20210251202A1 (da) |
EP (2) | EP4023059A1 (da) |
JP (3) | JP7182647B2 (da) |
KR (3) | KR102444180B1 (da) |
CN (2) | CN112312766A (da) |
AU (2) | AU2019287727B2 (da) |
CA (1) | CA3103646C (da) |
DK (1) | DK3629720T3 (da) |
ES (1) | ES2907067T3 (da) |
HR (1) | HRP20220509T8 (da) |
IL (2) | IL279311B2 (da) |
LT (1) | LT3629720T (da) |
MX (2) | MX2020013652A (da) |
PL (1) | PL3629720T3 (da) |
PT (1) | PT3629720T (da) |
RS (1) | RS63117B1 (da) |
SG (1) | SG11202012084WA (da) |
SI (1) | SI3629720T1 (da) |
WO (1) | WO2019241692A1 (da) |
ZA (1) | ZA202007560B (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112312766A (zh) * | 2018-06-14 | 2021-02-02 | 瑞泽恩制药公司 | 在免疫球蛋白重链编码序列中具有dh-dh重排能力的非人动物 |
JP2023540808A (ja) | 2020-09-11 | 2023-09-26 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 抗原特異的抗体の同定及び産生 |
JP2024500399A (ja) | 2020-12-16 | 2024-01-09 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒト化Fcアルファ受容体を発現するマウス |
Family Cites Families (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
EP0463151B1 (en) | 1990-01-12 | 1996-06-12 | Cell Genesys, Inc. | Generation of xenogeneic antibodies |
US5814318A (en) | 1990-08-29 | 1998-09-29 | Genpharm International Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
DE69127627T2 (de) | 1990-08-29 | 1998-02-19 | Genpharm Int | Produktion und Nützung nicht-menschliche transgentiere zur Produktion heterologe Antikörper |
US5670356A (en) | 1994-12-12 | 1997-09-23 | Promega Corporation | Modified luciferase |
US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
US5874304A (en) | 1996-01-18 | 1999-02-23 | University Of Florida Research Foundation, Inc. | Humanized green fluorescent protein genes and methods |
EP1500329B1 (en) | 1996-12-03 | 2012-03-21 | Amgen Fremont Inc. | Human antibodies that specifically bind human TNF alpha |
GB9823930D0 (en) | 1998-11-03 | 1998-12-30 | Babraham Inst | Murine expression of human ig\ locus |
US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
MXPA03008454A (es) | 2001-03-22 | 2004-06-30 | Abbott Gmbh & Co Kg | Animales transgenicos que expresan anticuerpos especificos para genes de interes y usos de los mismos. |
US7744893B2 (en) * | 2002-06-05 | 2010-06-29 | Baylor College Of Medicine | T cell receptor CDR3 sequences associated with multiple sclerosis and compositions comprising same |
US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
JP5514539B2 (ja) | 2006-03-31 | 2014-06-04 | メダレックス・リミテッド・ライアビリティ・カンパニー | ヒト抗体の調製に用いるためのキメラ抗体を発現するトランスジェニック動物 |
DK2374818T3 (da) | 2006-06-02 | 2013-01-21 | Regeneron Pharma | Højaffinitetsantistoffer mod human IL-6-receptor |
LT2602323T (lt) | 2007-06-01 | 2018-04-10 | Open Monoclonal Technology, Inc. | Kompozicijos ir būdai endogeninių imunoglobulinų genams slopinti ir transgeniniams žmogaus idiotipo antikūnams gaminti |
TWI476280B (zh) | 2008-03-07 | 2015-03-11 | Regeneron Pharma | 來自二倍體宿主胚胎注射之es-細胞衍生的老鼠 |
HUE057994T2 (hu) | 2008-06-27 | 2022-06-28 | Merus Nv | Antitesttermelõ, transzgenikus, egérfélékhez tartozó állat |
WO2010039900A2 (en) | 2008-09-30 | 2010-04-08 | Aliva Biopharmaceuticals, Inc. | Non-human mammals for the production of chimeric antibodies |
EP2792236B2 (en) | 2009-07-08 | 2023-03-22 | Kymab Limited | Animal models and therapeutic molecules |
SG181477A1 (en) | 2009-12-10 | 2012-07-30 | Regeneron Pharma | Mice that make heavy chain antibodies |
HUE045591T2 (hu) | 2010-02-08 | 2019-12-30 | Regeneron Pharma | Közönséges könnyûláncú egér |
US9796788B2 (en) | 2010-02-08 | 2017-10-24 | Regeneron Pharmaceuticals, Inc. | Mice expressing a limited immunoglobulin light chain repertoire |
US20130185821A1 (en) | 2010-02-08 | 2013-07-18 | Regeneron Pharmaceuticals, Inc. | Common Light Chain Mouse |
US20120021409A1 (en) | 2010-02-08 | 2012-01-26 | Regeneron Pharmaceuticals, Inc. | Common Light Chain Mouse |
US20130045492A1 (en) | 2010-02-08 | 2013-02-21 | Regeneron Pharmaceuticals, Inc. | Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain |
KR20210010942A (ko) | 2010-03-31 | 2021-01-28 | 아블렉시스, 엘엘씨 | 키메라 항체의 제조를 위한 비-인간 동물의 유전적 조작 |
ES2576928T3 (es) | 2010-06-22 | 2016-07-12 | Regeneron Pharmaceuticals, Inc. | Ratones que expresan una cadena ligera con las regiones variable lambda humana y constante de ratón |
JP6482757B2 (ja) | 2010-07-26 | 2019-03-13 | トリアンニ インコーポレイテッドTrianni,Inc. | トランスジェニック動物および使用方法 |
RU2750219C2 (ru) | 2010-08-02 | 2021-06-24 | Ридженерон Фармасьютикалз, Инк. | Мыши, у которых вырабатываются связывающие белки, содержащие vl-домены |
RS59661B2 (sr) | 2011-02-25 | 2023-06-30 | Regeneron Pharma | Adam6 miševi |
AU2012311288B2 (en) * | 2011-09-19 | 2017-08-17 | Kymab Limited | Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics |
CA2791109C (en) | 2011-09-26 | 2021-02-16 | Merus B.V. | Generation of binding molecules |
HUE057680T2 (hu) | 2011-10-17 | 2022-06-28 | Regeneron Pharma | Korlátozott immunglobulin-nehézlánccal rendelkezõ egerek |
DK2773671T3 (da) | 2011-11-04 | 2021-11-15 | Zymeworks Inc | Udformning af stabilt heterodimert antistof med mutationer i fc-domænet |
RS59699B1 (sr) * | 2012-02-01 | 2020-01-31 | Regeneron Pharma | Humanizovani miševi koji eksprimiraju teške lance koji sadrže vl domene |
SG11201405088QA (en) | 2012-03-06 | 2014-11-27 | Regeneron Pharma | Common light chain mouse |
KR102459666B1 (ko) | 2012-03-16 | 2022-10-27 | 리제너론 파마슈티칼스 인코포레이티드 | pH-민감성 면역글로불린 서열을 발현하는 비-사람 동물 |
US20140013456A1 (en) | 2012-03-16 | 2014-01-09 | Regeneron Pharmaceuticals, Inc. | Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same |
MX2014011047A (es) | 2012-03-16 | 2015-04-08 | Regeneron Pharma | Ratones que producen proteinas de union a un antigeno con caracteristicas de union dependientes del ph. |
MY172730A (en) | 2012-03-16 | 2019-12-11 | Regeneron Pharma | Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same |
SG11201407644UA (en) | 2012-06-05 | 2014-12-30 | Regeneron Pharma | Methods for making fully human bispecific antibodies using a common light chain |
PL2931030T5 (pl) | 2012-12-14 | 2024-06-10 | Open Monoclonal Technology, Inc. | Polinukleotydy kodujące przeciwciała gryzoni z ludzkimi idiotypami i zawierające je zwierzęta |
MY178882A (en) * | 2013-02-20 | 2020-10-21 | Regeneron Pharma | Non-human animals with modified immunoglobulin heavy chain sequences |
PL2967013T3 (pl) | 2013-03-13 | 2019-07-31 | Regeneron Pharmaceuticals, Inc. | Mysz, w której zachodzi ekspresja ograniczonego repertuaru lekkiego łańcucha immunoglobuliny |
SG11201506294TA (en) | 2013-03-13 | 2015-09-29 | Regeneron Pharma | Common light chain mouse |
HUE056903T2 (hu) | 2013-04-16 | 2022-04-28 | Regeneron Pharma | Patkány genom célzott módosítása |
US9475559B2 (en) | 2013-07-03 | 2016-10-25 | Hobie Cat Company | Foot operated propulsion system for watercraft |
ES2762640T3 (es) * | 2014-03-21 | 2020-05-25 | Regeneron Pharma | Proteínas VL de unión a antígeno que exhiben diferentes características de unión |
WO2015143414A2 (en) * | 2014-03-21 | 2015-09-24 | Regeneron Pharmaceuticals, Inc. | Non-human animals that make single domain binding proteins |
PL3354732T3 (pl) | 2014-06-23 | 2020-06-15 | Regeneron Pharmaceuticals, Inc. | Łączenie dna mediowane nukleazą |
JP6727199B2 (ja) | 2014-11-21 | 2020-07-22 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. | ガイドrnaのペアを使用したターゲティングによる遺伝子改変の方法及び組成物 |
US9410301B2 (en) | 2014-12-09 | 2016-08-09 | Theophile Bourgeois | Patch system and method for oil boom |
ES2760508T3 (es) | 2014-12-19 | 2020-05-14 | Regeneron Pharma | Métodos y composiciones para la modificación genética dirigida a través de la transformación múltiple en una sola etapa |
CN107438622A (zh) | 2015-03-19 | 2017-12-05 | 瑞泽恩制药公司 | 选择结合抗原的轻链可变区的非人动物 |
PT3462853T (pt) | 2016-06-03 | 2023-04-21 | Regeneron Pharma | Animais não humanos que expressam desoxinucleotidiltransferase terminal exógena |
AU2017391167B2 (en) | 2016-11-04 | 2024-02-15 | Regeneron Pharmaceuticals, Inc. | Non-human animals having an engineered immunoglobulin lambda light chain locus |
CN207626880U (zh) | 2017-05-19 | 2018-07-20 | 厦门汇成峰户外用品有限公司 | 一种导演椅 |
EP3476942B1 (en) * | 2017-10-27 | 2022-01-26 | Trianni, Inc. | Long germline dh genes and long hcdr3 antibodies |
US20210345591A1 (en) | 2017-12-05 | 2021-11-11 | Regeneron Pharmaceuticals, Inc. | Non-human animals having an engineered immunoglobulin lambda light chain and uses thereof |
CN112312766A (zh) * | 2018-06-14 | 2021-02-02 | 瑞泽恩制药公司 | 在免疫球蛋白重链编码序列中具有dh-dh重排能力的非人动物 |
-
2019
- 2019-06-14 CN CN201980039940.2A patent/CN112312766A/zh active Pending
- 2019-06-14 KR KR1020207036226A patent/KR102444180B1/ko active IP Right Grant
- 2019-06-14 JP JP2020569099A patent/JP7182647B2/ja active Active
- 2019-06-14 AU AU2019287727A patent/AU2019287727B2/en active Active
- 2019-06-14 ES ES19737613T patent/ES2907067T3/es active Active
- 2019-06-14 EP EP21213824.2A patent/EP4023059A1/en active Pending
- 2019-06-14 US US17/252,014 patent/US20210251202A1/en active Pending
- 2019-06-14 LT LTEPPCT/US2019/037285T patent/LT3629720T/lt unknown
- 2019-06-14 DK DK19737613.0T patent/DK3629720T3/da active
- 2019-06-14 SG SG11202012084WA patent/SG11202012084WA/en unknown
- 2019-06-14 CA CA3103646A patent/CA3103646C/en active Active
- 2019-06-14 RS RS20220366A patent/RS63117B1/sr unknown
- 2019-06-14 WO PCT/US2019/037285 patent/WO2019241692A1/en active Application Filing
- 2019-06-14 IL IL279311A patent/IL279311B2/en unknown
- 2019-06-14 PT PT197376130T patent/PT3629720T/pt unknown
- 2019-06-14 CN CN202110654221.0A patent/CN113430207A/zh active Pending
- 2019-06-14 KR KR1020237034902A patent/KR20230147213A/ko active Application Filing
- 2019-06-14 SI SI201930180T patent/SI3629720T1/sl unknown
- 2019-06-14 HR HRP20220509TT patent/HRP20220509T8/hr unknown
- 2019-06-14 PL PL19737613T patent/PL3629720T3/pl unknown
- 2019-06-14 US US16/442,063 patent/US20190380316A1/en active Pending
- 2019-06-14 IL IL305557A patent/IL305557A/en unknown
- 2019-06-14 EP EP19737613.0A patent/EP3629720B1/en active Active
- 2019-06-14 KR KR1020227031578A patent/KR102617284B1/ko active IP Right Grant
- 2019-06-14 MX MX2020013652A patent/MX2020013652A/es unknown
-
2020
- 2020-12-04 ZA ZA2020/07560A patent/ZA202007560B/en unknown
- 2020-12-14 MX MX2022004537A patent/MX2022004537A/es unknown
-
2022
- 2022-03-30 JP JP2022056227A patent/JP2022079617A/ja not_active Withdrawn
- 2022-11-10 AU AU2022268350A patent/AU2022268350A1/en active Pending
-
2023
- 2023-12-21 JP JP2023215643A patent/JP2024019660A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3676297T3 (da) | Forbindelser, sammensætninger og fremgangsmåder | |
DK3223605T3 (da) | Ikke-humane dyr, der eksprimerer humaniseret cd3-kompleks | |
DK3675410T3 (da) | Opnåelse og angivelse af komponentkombination, der anvendes til CSI-RS | |
DK3629720T3 (da) | Ikke-humane dyr, der er i stand til at omarrangere DH-DH i immunoglobulin-tungkæde-kodningssekvenser | |
DK3743337T3 (da) | Vilkårlig kasselukker | |
DK3504832T3 (da) | Fremgangsmåder til effektiv signalering i V2X-kommunikation | |
DK3689033T3 (da) | Effektiv PLMN-kodning til 5G | |
DK3760633T3 (da) | Oxazino-quinazolin og oxazino-quinazolinforbindelse, fremgangsmåde til fremstilling deraf og anvendelser deraf | |
DE112019000774A5 (de) | Spannvorrichtung | |
CL2018001921S1 (es) | Émbolo. | |
DK3758777T3 (da) | Sprøjtestempelindgrebsmekanisme | |
DK3337821T3 (da) | Immunoassay til kollagen type VII sekvenser | |
DE112020005591A5 (de) | Reihenklemmenelement | |
DE112019002885A5 (de) | Laschenkette | |
DK3611404T3 (da) | Kædetandhjul | |
ES1227530Y (es) | Llavero | |
MA54307A (fr) | Archive | |
UA38406S (uk) | Електрична ланцюгова пила | |
CL2019000984S1 (es) | Piedra preciosa. | |
DE112019004521A5 (de) | Laschenkette | |
UA38324S (uk) | Лещата | |
UA35691S (uk) | Котушка з ланцюгом пиляльним | |
UA39442S (uk) | Болт | |
UA41399S (uk) | Довгогубці | |
DE112019006370A5 (de) | Strahlungsemittierendes bauelement |